English

AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors

Biological Physics 2024-01-05 v1

Abstract

Comparison of click chemistry and sortagging grafting strategies for functionalizing AGuIX nanoparticles with nanobodies to develop a tri-functional technology combining MRI imaging, radiotherapy, and immunotherapy by inhibiting immune checkpoints.

Keywords

Cite

@article{arxiv.2401.02149,
  title  = {AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors},
  author = {Léna Carmès and Guillaume Bort and François Lux and Léa Seban and Paul Rocchi and Zeinaf Muradova and Agnès Hagège and Laurence Heinrich-Balard and Frédéric Delolme and Virginie Gueguen-Chaignon and Charles Truillet and Stephanie Crowley and Elisa Bello and Tristan Doussineau and Michael Dougan and Olivier Tillement and Jonathan Schoenfeld and Needa Brown and Ross Berbeco},
  journal= {arXiv preprint arXiv:2401.02149},
  year   = {2024}
}

Comments

Nanoscale, 2024